News and Views


Nature Immunology 10, 568 - 570 (2009)
doi:10.1038/ni0609-568

IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation

Amit Awasthi1 & Vijay K Kuchroo1

  1. Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
    e-mail: vkuchroo@rics.bwh.harvard.edu


T helper type 1 cells (TH1 cells) serve a dominant function in T cell–mediated colitis. New work reports that interleukin 17A, an effector cytokine required for the development of autoimmune tissue inflammation, directly inhibits TH1 development by suppressing the expression of key TH1-associated genes and therefore regulates TH1 cell–mediated colitis.

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

IL-23: a master regulator in Crohn disease

Nature Medicine News and Views (01 Jan 2007)

IL-23: a master regulator in Crohn disease

Nature Medicine News and Views (01 Jan 2007)

See all 3 matches for News And Views

Extra navigation

Subscribe to Nature Immunology

Subscribe

Open Innovation Challenges

ADVERTISEMENT